Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genta Inc.

www.genta.com

Latest From Genta Inc.

Stockwatch: Alnylam Helps Nucleic Acid Drugs Degrade

Clinical trial failures and holds for drugs derived from nucleic acids from Alnylam and Ionis join those of Dicerna and Genta as the hit rate for these drugs continues to degrade. The real question is whether the failures have been due to a lack of efficacy or safety.

Research & Development Clinical Trials

AbbVie, Roche Claim Important Win For Venetoclax In CLL

Partners AbbVie and Roche's Genentech scored an important win for their B-cell lymphoma-2 (BCL-2) inhibitor venetoclax in a Phase II clinical trial that met the study's primary endpoint in hard-to-treat chronic lymphocytic leukemia (CLL) patients, setting the stage for potential accelerated approval.

Cancer

Genta Postscript: Defunct Company’s Former President Charged With Insider Trading

Loretta Itri told a longtime friend of the negative results of a Phase III study of Genasense in advanced melanoma before the news was public.

BioPharmaceutical United States

Making Genasense, finally; Genta ends bankrupt

Despite putting up a fight, Genta has resorted to filing for Chapter 7 bankruptcy with the company's directors resigning with immediate effect.

Cancer United States
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Genta Inc.
  • Senior Management
  • Raymond P Warrell Jr., MD, Chmn. & CEO
    Gary Siegel, VP, Fin.
    Loretta M Itri, MD, Pres., Pharmaceutical Dev. & CMO
  • Contact Info
  • Genta Inc.
    Phone: (908) 286-9800
    200 Connell Dr.
    Berkeley Heights, NJ 07922
    USA
UsernamePublicRestriction

Register